Publication | Closed Access

Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?

InflammationBone DiseaseDental ConditionsMedication-related OsteonecrosisOsteoarthritisDental DiseaseHigh-dose Bone-modifying AgentsRheumatoid ArthritisOsteoporosisBone HomeostasisMedicineOrthopaedic SurgeryDental Infections